Challenges and practical recommendations for successfully recruiting inactive, statin-free older adults to clinical

Colleen S Deane1,2, Bethan E Phillips3, Kenneth Smith3

  • 1Department of Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, St. Luke's Campus, Exeter, EX1 2LU, UK. c.s.deane@exeter.ac.uk.

BMC Research Notes
|March 27, 2020
PubMed
Abstract

Insights

Recruiting inactive, statin-free older adults for clinical trials is challenging. A multi-pronged approach using databases, social media, and community outreach is recommended for efficient participant enrollment.

Area of Science:

  • Gerontology
  • Clinical Trial Design
  • Metabolic Research

Background:

  • Older adults are a key demographic for health and metabolic studies.
  • Exclusion criteria, such as statin use, can complicate recruitment.
  • Inactive, statin-free older males present unique recruitment challenges.

Purpose of the Study:

  • To detail the difficulties in recruiting inactive, statin-free older adults.
  • To offer practical strategies for feasible clinical trial designs.
  • To report recruitment outcomes from a specific clinical trial.

Main Methods:

  • A double-blind, randomized controlled trial (RCT) was used.
  • Recruitment targeted inactive, statin-free males aged 65-75 years.
  • Multiple recruitment channels were employed, including databases, social media, and direct mail.

Main Results:

  • The study aimed to recruit 20 volunteers in 12 months but took 25 months.
  • Extensive outreach efforts reached over 120,000 individuals.
  • 20 volunteers were recruited, with 18 completing the trial.

Conclusions:

  • Recruiting this specific population is time-consuming and difficult.
  • A comprehensive, multi-channel recruitment strategy is essential.
  • Prioritizing volunteer databases, social media, and recruitment talks is advised.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
91
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
268
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
142
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
168
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
146
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
190